World's first COVID-19 vaccine trial to deliberately infect volunteers with a new one
First, the subjects will be vaccinated, and latera month they will be infected with the Sars-CoV-2 virus. This is necessary to test the effectiveness of the product. After infection, the volunteers will be placed under the supervision of doctors at a specialized clinic in the Whitechapel area in east London. Doctors will reduce the risk of complications with the help of the antiviral drug Remdesivir.
The publication suggests that the organizers will select from several dozen to several hundred healthy young people, each of whom will receive more than £ 4,000 (about 400,000 rubles at the current exchange rate).
These studies, according to sources, could begin in January 2021 at a safe quarantine facility in London.
The Doomsday glacier turned out to be more dangerous than scientists thought. We tell the main thing
GitHub has replaced the term "master" with a neutral equivalent
Two pieces of evidence of extraterrestrial life emerged at once. One is on Venus, the other is unknown